H.U. Group Holdings, Inc. (TYO:4544)

Market Cap	182.99B +13.6%
Revenue (ttm)	247.36B +1.8%
Net Income	6.82B +147.1%
EPS	121.42 +149.9%
Shares Out	55.49M
PE Ratio	27.16
Forward PE	33.23
Dividend	125.00 (3.79%)
Ex-Dividend Date	Mar 30, 2026

Volume	288,600
Open	3,283.00
Previous Close	3,302.00
Day's Range	3,232.00 - 3,298.00
52-Week Range	2,944.50 - 4,093.00
Beta	0.26
Analysts	Hold
Price Target	3,140.00 (-4.79%)
Earnings Date	May 14, 2026

About H.U. Group Holdings

H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment provides general testing services to medical institutions that include esoteric testing, such as genetic and oncology testing; companion diagnostics-related tests for cancer treatment; omics analysis comprising whole genome sequencing and proteome analysis; comprehensive support for clinical trials and research, including pre-trial setup work, specimen ...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1950
• Employees: 5,444
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4544

Financial Performance

In fiscal year 2026, H.U. Group Holdings's revenue was 247.36 billion, an increase of 1.78% compared to the previous year's 243.03 billion. Earnings were 6.82 billion, an increase of 147.12%.